Security Snapshot

ULTRALIFE CORP - Common Stock, $.10 par value per share (ULBI) Institutional Ownership

CUSIP: 903899102

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

50

Shares (Excl. Options)

5,326,090

Price

$6.52

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / Common Stock, $.10 par value per share
Symbol
ULBI on Nasdaq
Shares outstanding
16,666,558
Price per share
$6.52
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
5,326,090
Total reported value
$34,724,476
% of total 13F portfolios
0%
Share change
-224,731
Value change
-$1,299,303
Number of holders
50
Price from insider filings
$6.52
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • ULBI - ULTRALIFE CORP - Common Stock, $.10 par value per share is tracked under CUSIP 903899102.
  • 50 institutions reported positions in Q1 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 59 to 50 between Q4 2025 and Q1 2026.
  • Reported value moved from $32,094,777 to $34,724,476.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 50 institutions filings for Q1 2026.

Open SEC Evidence

Security key

903899102

Latest holder period

Q1 2026

13F holders

50

13D/G owners

2

CIK / CUSIP context first

Open Q1 2026 holders ULBI full holder history ULTRALIFE CORP SEC filings ULTRALIFE CORP company facts ULTRALIFE CORP insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Significant Owners of ULTRALIFE CORP - Common Stock, $.10 par value per share (ULBI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WHITMORE BRADFORD T 40% $37,751,754 6,599,957 WHITMORE BRADFORD T 12 Mar 2026
Visionary Wealth Advisors 6.6% -15% $6,235,984 -$1,159,038 1,090,207 -16% Visionary Wealth Advisors 31 Dec 2025

As of 31 Mar 2026, 50 institutional investors reported holding 5,326,090 shares of ULTRALIFE CORP - Common Stock, $.10 par value per share (ULBI). This represents 32% of the company’s total 16,666,558 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ULTRALIFE CORP - Common Stock, $.10 par value per share (ULBI) together control 31% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Visionary Wealth Advisors 6.6% 1,106,154 +1.5% 0.32% $7,212,125
DIMENSIONAL FUND ADVISORS LP 6% 994,846 -0.58% 0% $6,486,040
Janney Montgomery Scott LLC 3.1% 518,000 +2% 0.01% $3,377,000
VANGUARD CAPITAL MANAGEMENT LLC 2.7% 457,837 0% 0% $2,985,097
Truffle Hound Capital, LLC 1.5% 250,000 0% 1% $1,630,000
RBF Capital, LLC 1.3% 218,714 -2.8% 0.07% $1,426,015
RENAISSANCE TECHNOLOGIES LLC 1.2% 198,090 -6.1% 0% $1,291,547
Connor, Clark & Lunn Investment Management Ltd. 0.93% 155,021 +2.2% 0% $1,010,737
BlackRock, Inc. 0.88% 146,273 +0.12% 0% $953,700
RAYMOND JAMES FINANCIAL INC 0.84% 139,333 +24% 0% $908,452
GEODE CAPITAL MANAGEMENT, LLC 0.76% 127,339 +6.2% 0% $830,802
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.76% 126,753 -7.1% 0% $826,430
Teton Advisors, LLC 0.65% 109,000 0% 0.5% $710,680
ACADIAN ASSET MANAGEMENT LLC 0.5% 83,799 0% 0% $545,000
Russell Investments Group, Ltd. 0.49% 81,791 +67% 0% $533,276
LSV ASSET MANAGEMENT 0.39% 64,500 0% 0% $421,000
VANGUARD FIDUCIARY TRUST CO 0.38% 63,066 0% 0% $411,190
TWO SIGMA INVESTMENTS, LP 0.37% 62,225 +8.4% 0% $405,707
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.36% 59,579 0% 0.01% $388,455
Ancora Advisors LLC 0.34% 56,169 +22% 0.01% $366,222
STATE STREET CORP 0.26% 42,820 +5.2% 0% $279,186
CITADEL ADVISORS LLC 0.25% 41,301 -55% 0% $269,283
AMERIPRISE FINANCIAL INC 0.22% 36,150 -1.2% 0% $235,698
Walleye Capital LLC 0.2% 32,880 -13% 0% $214,378
NORTHERN TRUST CORP 0.18% 29,231 -0.82% 0% $190,586

Institutional Holders of ULTRALIFE CORP - Common Stock, $.10 par value per share (ULBI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 5,326,090 $34,724,476 -$1,299,303 $6.52 50
2025 Q4 5,611,465 $32,094,777 -$557,686 $5.72 59
2025 Q3 5,711,143 $38,948,604 -$190,967 $6.82 62
2025 Q2 5,608,393 $50,360,042 -$1,967,737 $8.98 61
2025 Q1 5,927,266 $31,887,300 -$1,903,352 $5.38 70
2024 Q4 6,273,891 $46,738,246 +$1,465,553 $7.45 66
2024 Q3 6,043,039 $54,690,941 -$941,259 $9.04 74
2024 Q2 6,048,765 $64,235,639 +$10,026,682 $10.62 70
2024 Q1 5,150,472 $45,375,589 +$1,441,086 $8.81 60
2023 Q4 5,013,719 $34,190,882 +$1,682,466 $6.82 53
2023 Q3 4,669,553 $45,574,879 +$5,098,401 $9.76 49
2023 Q2 4,172,822 $20,195,823 -$556,186 $4.84 31
2023 Q1 4,274,553 $17,182,141 +$80,314 $4.02 27
2022 Q4 4,237,358 $16,355,291 +$422,170 $3.86 29
2022 Q3 4,140,684 $19,915,939 -$1,043,988 $4.81 24
2022 Q2 4,369,230 $20,015,834 -$541,140 $4.55 24
2022 Q1 4,497,986 $24,151,616 -$1,058,805 $5.37 27
2021 Q4 4,689,456 $28,326,877 -$1,956,325 $6.04 28
2021 Q3 4,937,278 $35,111,639 -$858,297 $7.09 37
2021 Q2 5,038,104 $42,378,665 -$4,335,936 $8.38 48
2021 Q1 5,558,891 $46,034,445 +$4,679,250 $8.28 54
2020 Q4 5,363,782 $34,704,477 -$1,508,376 $6.47 47
2020 Q3 5,573,496 $32,891,003 -$1,111,394 $5.90 44
2020 Q2 5,748,504 $40,229,143 +$1,784,463 $7.01 45
2020 Q1 5,574,996 $28,990,300 -$2,309,496 $5.20 35
2019 Q4 6,009,684 $44,409,848 -$332,736 $7.39 32
2019 Q3 5,228,967 $45,279,165 -$143,391 $8.66 31
2019 Q2 5,257,325 $41,795,988 -$42,001 $7.95 35
2019 Q1 5,169,343 $53,084,568 +$3,421,695 $10.27 40
2018 Q4 5,024,594 $33,914,688 -$2,859,492 $6.75 32
2018 Q3 5,314,920 $43,314,000 +$3,672,680 $8.15 34
2018 Q2 5,251,755 $50,416,000 +$3,875,280 $9.60 36
2018 Q1 4,846,658 $48,466,000 +$6,030,695 $10.00 37
2017 Q4 4,281,775 $28,040,000 +$1,327,949 $6.55 33
2017 Q3 4,075,992 $27,514,000 +$1,902,322 $6.75 36
2017 Q2 3,813,053 $27,448,000 +$4,378,475 $7.20 40
2017 Q1 3,220,454 $17,417,000 +$962,227 $5.44 32
2016 Q4 3,156,610 $15,623,850 -$471,104 $4.95 36
2016 Q3 3,261,234 $13,374,864 -$346,066 $4.11 41
2016 Q2 3,339,016 $16,727,024 -$208,602 $5.01 39
2016 Q1 3,375,920 $17,284,000 -$185,747 $5.12 43
2015 Q4 3,395,486 $21,932,000 +$1,983,261 $6.46 45
2015 Q3 3,090,818 $18,203,000 -$3,291,558 $5.89 33
2015 Q2 3,651,155 $15,297,000 -$4,822,570 $4.19 33
2015 Q1 4,850,992 $19,217,000 -$260,079 $3.94 30
2014 Q4 4,953,259 $15,502,000 -$462,538 $3.13 29
2014 Q3 5,096,683 $16,510,000 -$396,278 $3.24 35
2014 Q2 5,217,530 $20,035,000 -$206,789 $3.84 31
2014 Q1 5,269,934 $22,379,000 +$772,365 $4.25 32
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .